Chronic Hepatitis B and Leishmania Coinfection.

Visceral leishmaniasis is an endemic disease in many parts of world, and if untreated, it is a potentially life-threatening infectious disease. It is similar to chronic liver disease because of signs and symptoms such as fever, weight loss, hepatosplenomegaly, and pancytopenia. In this study, we present a case of visceral leishmaniasis, which is known to be a chronic hepatitis B infection, that was coincidentally diagnosed with liver biopsy. Visceral leishmaniasis should be considered as an infectious disease in the differential diagnosis of chronic liver diseases.

[1]  O. Singh,et al.  Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective , 2016, Infectious Diseases of Poverty.

[2]  S. Levidiotou,et al.  Laboratory diagnosis of human visceral leishmaniasis. , 2016, Journal of vector borne diseases.

[3]  R. López-Vélez,et al.  Leishmaniasis in immunosuppressed individuals. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  S. Solmaz,et al.  [Evaluation of fourteen adult cases with visceral leishmaniasis]. , 2013, Mikrobiyoloji bulteni.

[5]  S. Solmaz,et al.  Delayed and overlooked diagnosis of an unusual opportunistic infection in a renal transplant recipient: visceral leishmaniasis. , 2010, Turkiye parazitolojii dergisi.

[6]  N. Urgancı,et al.  [Case report: the efficacy of amphotericin B in visceral leishmaniasis]. , 2010, Turkiye parazitolojii dergisi.

[7]  C. Tripodo,et al.  Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report , 2009, Journal of medical case reports.

[8]  Detlef Schuppan,et al.  Liver cirrhosis , 2008, The Lancet.

[9]  H. Schallig,et al.  [Investigation of Leishmania infantum seropositivity in HIV/AIDS patients]. , 2008, Mikrobiyoloji bulteni.

[10]  A. Prakash,et al.  Visceral leishmaniasis masquerading as chronic liver disease. , 2006, The Journal of the Association of Physicians of India.

[11]  Shyam Sundar,et al.  Liposomal amphotericin B for the treatment of visceral leishmaniasis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  S. Reed,et al.  Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. , 1998, The American journal of tropical medicine and hygiene.

[13]  R. Pearson,et al.  Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. , 1990 .